The aim of this application is to develop a patient-oriented mentoring and research program in adult gastroenterology at Baylor College of Medicine. By establishing a methodological and content based program, we will provide mentorship and research opportunities to students, fellows and junior physician and PhD faculty interested in pursuing independent research careers in Epidemiology and Outcomes research in digestive and liver disorders. The proposed program will be interdisciplinary in nature and will be facilitated by the interaction between physicians and scientists in the Sections of Health services Research and Gastroenterology at Baylor College of Medicine. The applicant has MD and MPH degrees and is a gastroenterologist and epidemiologist. He has faculty appointments in both Baylor sections, and is the Chief of the Clinical Epidemiology Division within the Houston Center for Quality of Care and Utilization Studies. His research interests focus on the clinical epidemiology and outcomes of GERD and Barrett's esophagus as well as hepatocellular carcinoma. The proposed program is based on current research projects conducted by the applicant and the planned continuation projects arising from this research, including: (1) Patterns, Determinants, and Outcomes of Screening For Hepatocellular Carcinoma.
The aims of this study are to determine the patterns (prevalence, type and frequency) of utilization of pre-diagnosis screening for HCC in patients diagnosed with HCC;to examine the determinants of screening among patients diagnosed with HCC, including patient characteristics, socioeconomic status, and physician provider factors;to examine the patterns and determinants of utilization of potentially curative therapy (resection, transplantation, local ablation) among patients with HCC and to determine the impact of screening on the utilization of HCC therapy;and to determine the impact of pre-diagnosis HCC screening on mortality of patients diagnosed with HCC. (2) Obesity. H. pylori, and the risk of Barrett's esophagus.
The aims of this study is to estimate the effects of the amount and distribution of total body fat, as well as abdominal obesity and the serum levels of adipocytokines on the prevalence of newly diagnosed BE;to examine the effect of H. pylori infection on the prevalence of newly diagnosed BE;to estimate the effect of BMI and abdominal obesity and the effect of H. pylori infection on the prevalence of newly diagnosed BE while adjusting for lifestyle, demographic, clinical and histological features;and to estimate the effect of BMI and abdominal obesity and the effect of H. pylori infection on BE tissue COX-2 expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24DK078154-04
Application #
7802970
Study Section
Special Emphasis Panel (ZDK1-GRB-W (J3))
Program Officer
Podskalny, Judith M,
Project Start
2007-05-01
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
4
Fiscal Year
2010
Total Cost
$122,016
Indirect Cost
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Vanga, Rohini R; Tansel, Aylin; Sidiq, Saad et al. (2018) Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 16:1220-1228.e4
Balakrishnan, M; El-Serag, H B (2018) Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis? Aliment Pharmacol Ther 47:437-438
Balakrishnan, Maya; El-Serag, Hashem B; Nguyen, Theresa et al. (2017) Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures. Clin Gastroenterol Hepatol 15:1965-1967
El-Serag, Hashem B; Kanwal, Fasiha; Richardson, Peter et al. (2016) Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology 64:130-7
Thrift, Aaron P; Anderson, Lesley A; Murray, Liam J et al. (2016) Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol 111:1528-1535
Ness-Jensen, Eivind; Hveem, Kristian; El-Serag, Hashem et al. (2016) Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol 14:175-82.e1-3
Khalaf, N; Ramsey, D; Kramer, J R et al. (2015) Personal and family history of cancer and the risk of Barrett's esophagus in men. Dis Esophagus 28:283-90
Singal, Amit G; El-Serag, Hashem B (2015) Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clin Gastroenterol Hepatol 13:2140-51
Qumseya, Bashar J; Brown, Jessica; Abraham, Merna et al. (2015) Diagnostic performance of EUS in predicting advanced cancer among patients with Barrett's esophagus and high-grade dysplasia/early adenocarcinoma: systematic review and meta-analysis. Gastrointest Endosc 81:865-74.e2
Shakhatreh, Mohammad H; Duan, Zhigang; Avila, Nathaniel et al. (2015) Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol 13:280-6

Showing the most recent 10 out of 82 publications